Recent data from the U.S. National Cancer Institute (NCI) indicates a significant decline in lung cancer diagnoses and deaths among both men and women over the past two decades.
This positive trend has contributed to an overall reduction in cancer mortality rates, showcasing a gradual yet notable change in the cancer landscape.
From 2001 to 2018, cancer deaths dropped by an average of 2.1 percent each year, further slowing to a 1.5 percent annual decline between 2018 and 2022.
The annual report, entitled ‘The Annual Report to the Nation on the Status of Cancer (ARN)’, highlights sustained declines in lung cancer as a major driver of these trends.
To reduce the risk of cancer-related deaths, the NCI report emphasizes the importance of quitting all forms of tobacco use and maintaining a healthy weight.
While lung cancer continues to be the leading cause of cancer death, there remains potential for improvement if tobacco usage continues to decrease and innovation in treatment progresses.
Moreover, increasing the rate of lung cancer screening—currently at only 18 percent for eligible adults—could lead to earlier detection and more effective treatment outcomes.
Despite advancements, lung cancer still accounts for the highest number of cancer-related fatalities, underscoring the need for ongoing vigilance in prevention and treatment efforts.
In contrast to the steady decline in smoking-related cancer deaths, the report reveals an increase in incidences of cancers linked to obesity over the same period.
Cancers associated with excess body weight include breast cancer in women, as well as cancers of the uterus, colon, rectum, pancreas, kidney, and liver.
Significantly, while lung cancer incidence rates are falling, cancers related to obesity have been rising—demonstrating a complex and concerning shift in cancer trends.
The treatment of cancer appears to be gradually improving, despite the fact that the incidence of cancer is not consistently decreasing.
Data indicates that men experienced a decline in cancer diagnoses from 2001 to 2013, after which rates plateaued until 2021.
In contrast, women saw a slight annual rise in overall cancer incidence from 2003 to 2021, except for a brief dip in 2020 due to the pandemic.
Specific indicators reveal noteworthy advancements in treatment efficacy; for instance, the breast cancer death rate has significantly decreased, even as new diagnoses have gradually risen.
Gender disparities in cancer incidence and mortality reveal important differences: men still experience higher rates of diagnosis and mortality compared to women, despite overall declines.
Prostate cancer remains the most prevalent form of cancer among men, while women face a greater incidence of stomach cancer.
The data also uncovers alarming racial and ethnic disparities in cancer outcomes.
Although overall progress is being made, Black women diagnosed with breast cancer face a 40 percent higher mortality rate compared to their White counterparts—a disparity that has persisted for many years.
The report emphasizes that while cancer incidence and death rates continue to decline, the enduring disparities based on race and ethnicity call for deeper analysis of the factors driving these differences.
These findings suggest there is still much work to be done to ensure equitable access to cancer care and successful outcomes for all demographic groups.
In conclusion, the report presents a cautiously optimistic picture of progress in the fight against cancer, highlighting areas for improvement and the need for ongoing dedication to specific battles in this ongoing war.
Readers are advised that this article is intended for informational purposes only and should not be considered medical advice.
image source from：https://www.discovermagazine.com/health/cancer-mortality-rates-declined-over-the-past-20-years-in-the-united-states
